Distribution of polyclonal hypergammaglobulinemia in different phases of chronic hepatitis B infection
Abstract
Background: Polyclonal hypergammaglobulinemia (PHGG) is commonly associated with liver disorders and could signify an enhanced or defective immune system. This study was conducted to determine the distribution and significance of PHGG in phases of chronic hepatitis B infection (CHB).
Methods: Serum protein electrophoresis and colorimetric protein were assayed in 80 inactive (IA), 45 immune-clearance (IC) and 17 immune-escape (IE) CHB participants. ANOVA and Student’s t-test were used for the comparison of data, while area under curve analysis was used to assess the performance.
Results: A significant elevation in γ-globulin was observed in the 3 phases studied in relation to non-hepatitis B virus-infected controls. The incidence of PHGG in different phases of CHB are IA (61.3%), IC (33.3%), and IE (29.4%). The IA phase, considered the least severe, has the highest incidence of PHGG.
Conclusion: Occurrence of PHGG seems to signify enhanced immune responses. It may also be used to some extent to predict the IA phase.
Statement of novelty: This study utilized both qualitative and quantitative methods to evaluate the patterns of PHGG in untreated and categorized CHB infections.
Formats available
You can view the full content in the following formats:
REFERENCES
Adedeji A.L., Adenikinju R.O., Ajele J.O., and Olawoye T.L. 2014. Electrophoresis of serum proteins as effective monitoring disease progression. EXCLI J. 13:761–771.
Adedeji, A.L., Jimoh, D., Badmus, J.A., Bello, I.O., Suleiman, I.E., and Ayelagbe, O.G. 2021. Elevated serum gamma globulins in apparently healthy Nigerians living in Ogbomoso: A possible manifestation of phagocytic dysfunction. LymphoSign J. 2021–0024
Al-Joudi F.S. and Wahab N.A. 2004. The Utilization of an index for Serum Globulin Compensation in Disease Associated with Decreased Serum Albumin. Med J. Malaysia, 59(4): 495–501.
Centers for Disease Control and Prevention (CDC). Viral hepatitis.cdc.gov/hepatitis [online] Available from https://www.cdc.gov/hepatitis/statistics/SurveiliianceRpts.htm [Accessed 13 September 2022]
Chojkier M. 2005. Inhibition of albumin synthesis in chronic diseases: molecular mechanisms. J. Clin. Gastroenterol. 39( 2): S143–S146.
Damburam A., Garbati M.A., and Yusuph H. 2012. Serum proteins in health and in patients with pulmonary tuberculosis in Nigeria. J. Infect. Dis. Immun. 4(2): 16–19.
Doumas B.T., Watson W.A., and Biggs H.G. 1971. Albumin estimation. Clin. Chem. Acta. 31: 87–89.
Fletcher J.G., Eapen E.C., and Abraham P. 2019. Hepatitis B genotyping: The utility for the Clinicians. Indian J. Gastroenterol. 39: 315–320.
Goa J. 1953. A Micro biuret method for protein determination in CSF. Scandinavian J. of Clin. and Lab. Invest. 5(3): 218–222.
Gregory B., Kristopher A., Micheal H., Tonya C., Lynda L., Kevin R., Stephen M., Juli D.G., Christie G., Jay S., Rae S., Patricia A.F., and Carolyn C. 2012. Protein electrophoresis of serum from healthy atlantic bottlenose dolphins (Tursiopstruncatus) Aquatic Mammals, 38(4): 412–417.
Hai-Jun L., Nai-Cui Z., Hong-Xiao S., Yang Y., An C., Tian-Yang L., and Zheng-Kun T. 2015. The role of immune cells in chronic HBV Infection. J. Clinical Transl. Hepatol. 3(4): 277–283.
Hao S., Wang Y., Gao G., and Li Z. 2017. Hepatitis B Virus upregulates the expression of C-reactive protein both in vivo and in vitro. Ann. Clin. Lab. Sci. 47(4): 432–435.
Hooijberg E.H., Miller M., Cray C., Buss P., Steenkamp G., and Goddard A. 2018. Serum protein electrophoresis in healthy and injured southern white rhinoceros (Ceratotherium ss) PLoS ONE, 13(7): e0200347.
Ibrahim O.B., Mohammed A., Abd Alla A., Ahmed S., and Alhadi R. 2016. Plasma protein patterns in pulmonary tuberculosis using protein electrophoresis. Sch. J. App. Med. Sci. 4(3D): 865–869
Karayiannis P. 2017. Hepatitis B virus: Virology, molecular biology, life cycle and intrahepatic spread. Hepatol Int. 11: 500–508.
Khakabimamaghani S., Najafi A., and Ranjbar R. 2013. GelClust: a software tool for gel electrophoresis images analysis and dendrogram generation. Comput. Methods Prog. Biomed. 111(2): 512–518.
Klair J.S., Vancura J., Arvind R., and Murali A.R. 2020. PRO: patients with chronic hepatitis b in immune-tolerant phase should be treated. Clin. Liver Dis. (Hoboken) 15(1): 21–24.
Lebherz-Eichinger D., Schwarzer R., Motal MC., Daniel A., Klaus D.A., Andreas Mangold A., Hendrik J., Ankersmit H.J., Berlakovich G.A., Krenn C.G., Georg A., and Roth G.A. 2015. Liver transplantation reverses hypergammaglobulinemia in patients with chronic hepatic failure. Biochem. Med. (Zagreb) 25(2): 252–261.
Li X., Wang Y., and Chen Y. 2014. Cellular immune response in patients with chronic hepatitis B virus infection. Microb. Pathog. 74: 59–62.
Marceline D.N., Justin W.S., Martin Luther K.M., Calixte P.I., and Annie Rosalie N.N. 2018. Serum protein electrophoresis as an added value for disease control among HIV patients in a hospital setting in Cameroon. J. AIDS and HIV Res. 10(7): 103–109.
Matsumoto A., Tanaka E., Morita S., Yoshizawa K., Umemura T., and Joshita S. 2012. Changes in the serum level of hepatitis B virus (HBV) surface antigen over the natural course of HBV infection. J Gastroenterol. 47: 1006–13.
Mendoza, F., and Lu, R. 2015. Basics of image analysis. J. Food Eng. 9–56.
Mohammad S., Hany A., Ashraf A., Kaneez F., Ghazi A.D., Esam A., Adel G.A.C., and Ishtiaq Q. 2014. Potential mechanism of hepatitis B virus-induced liver njury. World J Gastroenterol. 20(35): 12462–12472.
Musa B., Bussel S., Borodo M.M., Samaila A.A., and Femi O.L. 2015. Prevalence of Hepatitis B Virus Infection in Nigeria, 2000-2013: a systematic review and meta- analysis. Nigeria J. Clin. Practice. 18: 63–72.
Nimer A., Zaza B., Agness D., Gattas N., Maria G., and William N. 2009. Lower baseline ALT cut-off values and HBV DNA levels better differentiate HBeAg(-) chronic hepatitis B patients from inactive chronic carriers. World J Gastroenterol. 15(24): 3025–3031.
Pimenta F.M.C.A., Palma S.M.U., Constantino-Silva R.N., and Grumach A.S. 2019. Hypogammaglobulinemia: a diagnosis that must not be overlooked. Braz J. Med. Biol. Res. 52(10): e8926.
Pitaa I., Horta-Valeb A.M., Cardosob H., and Macedo G 2014. Hepatitis B inactive carriers: An overlooked population? GE Port J. Gastroenterol. 21(6): 241–249.
Pourkarim M.R., Amini-Bavil-Olyaee S., Kurbanov F., Rans V.M., and Tacke F. 2014. Molecular identification of hepatitis B virus genotypes/subgenotypes: revised classification hurdles and updated resolutions. World J. Gastroenterol. 20(23): 7152–7168.
Siegers M., Schutzler G., and Jarofke R. 1976. The effect of various stains on quantitative agarose-gel electrophoresis: Evaluation of the result with the aid of an analog computer. Clin. Chim. Acta, 73: 423–430.
Terrault N.A., Lok A.S.F., McMahoo B.J., Chang K., Hwanng J.P., Jonas M.M., Brown R.S., Bzowej N.H., and Wong J.B. 2018. Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis b guidance. Hepatology, 67(4): 1560–1599.
Tothova, C., Mihajlovicova, X., and Nagy, O. 2018. The use of serum proteins in the laboratory diagnosis of health disorders in ruminants. Ruminants Open acces peer-reviewed chapter.
WHO Executive Board (134th session). 2014. Hepatitis: improving the health of patients with viral hepatitis. Report by the Secretariat. WHO, Geneva. [online]. Available from http://apps.who.int/gb/ebwha/pdf_files/EB134/B134_36-en.pdf, [Accessed 10 June 2015].
Wiegand S.B., Beggel B., Wranke A., Aliabadi E., Jaroszewicz J., Xu C., Li Y., Manns M.P., Lengauer T., Wedemeyer H., Kraft A.R.M., Christine S., Falk C.S., and Cornberg M. 2019. Soluble immune markers in the different phases of chronic hepatitis B virus infection. Sci. Rep. 9: 14118–14123.
Yang H.C., Shih Y., and Liu C. 2017. Viral factors affecting the clinical outcomes of chronic hepatitis B. J. Infect. Dis. 216(S8): S757–S764.
Zhang S., Wu X., Ostroysky I., and Rand J. 2014. Improve method for estimating m-spike protein in serum protein electrophoresis. J. Clin. Exp. Pathol. 4(4): Open Access.
Zhuang T., Li Q.L., Chifang P., Zhenxing C., and Chuanlai X. 2009. A new development of measurement of 19-Nortestosterone by combining immunochromatographic strip assay and Image. J software. Food Agr. Immunol. 20(1): 1–10.
Information & Authors
Information
Published In
LymphoSign Journal
Volume 9 • Number 4 • December 2022
Pages: 92 - 99
History
Received: 12 June 2022
Accepted: 30 October 2022
Accepted manuscript online: 24 November 2022
Copyright
© 2022.
Authors
Metrics & Citations
Metrics
Other Metrics
Citations
Cite As
Adebayo LaurenceAdedeji, Ibrahim ElehaSuleiman, and Olubunmi GloriaAyelagbe. 2022. Distribution of polyclonal hypergammaglobulinemia in different phases of chronic hepatitis B infection. LymphoSign Journal.
9(4): 92-99. https://doi.org/10.14785/lymphosign-2022-0008
Export Citations
If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. Simply select your manager software from the list below and click Download.
There are no citations for this item
